Medtronic to expand vascular portfolio in $380M deal

Advertisement

Medtronic plans to acquire Contego Medical in a transaction valued at $380 million. The deal expands Medtronic’s portfolio of carotid technologies and includes Contego’s recently FDA-approved Neuroguard IEP Direct System and Excipio thrombectomy devices.

The Neuroguard IEP Direct System is the first and only transcarotid artery revascularization system with integrated embolic protection in addition to flow reversal, according to a Nov. 16 news release. In the PERFORMANCE III study, the system recorded no strokes, neurological deaths, cranial nerve injuries or myocardial infarctions at 30 days, according to the company.

Medtronic expects to complete the transaction in the third quarter of its fiscal year, subject to customary closing conditions.

Advertisement

Next Up in Supply Chain

Advertisement